2025 Featured Speakers

OCMF is honored to be featuring speakers from across a number of institutions and disciplines.

Featured Keynote

Joan Brugge, PhD

Louise Foote Pfeiffer Professor of Cell Biology (HMS), and Director of the Ludwig Center at Harvard Medical School.

Topic: TBA

Featured Keynote

Ernst Lengyel, MD, PhD

Arthur L. and Lee G. Herbst Distinguished Service Professor of Obstetrics and Gynecology
Chair, Department of Obstetrics and Gynecology at UChicago Medicine.

Topic: TBA

2025 Speakers

Monday, November 10th

David Piwnica-Worms, M.D, Ph.D.

“Novel b7H3-targete radioligand therapies for Ovarian Cancer”

University of Texas, MD Anderson Cancer Center

Scott Kaufmann, M.D, PhD

“PARP inhibitor resistance: Multiple mechanisms and still counting“
Mayo

Laura Wood, MD, PhD

“3D Genomic Analysis of Human Pancreatic Precancer”

John Hopkins University School of Medicine

Maggie Mullen, MD

“Targeting the COP9 signalsome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms“

WashU Medicine

Charles Ishak, PhD

“Contributions of chronic viral mimicry towards ovarian high grade serous carcinoma initiation”

University of Texas MD Anderson Cancer Center

Matt Block, MD, PhD

“A Th17 dendritic cell vaccine for ovarian cancer patients”

Mayo Clinic

Becky Stone, MD, MS

“Opportunistic salpingectomy”

Johns Hopkins Medicine

Joan Walker, MD

“Opportunistic salpingectomy & issues with STICs”

University of Oklahoma

Tuesday, November 11th

Zachary Watson, PhD

"Hematopoietic stem cell derived adipocytes influence the ovarian cancer microenvironment"

University of Colorado AMC

Mohammed Dwidar, PhD

"Engineering Microbes to Target and Reshape the Ovarian Tumor metabolic landscape"

Cleveland Clinic Foundation

Dineo Khabele, MD, FACOG, FACS

“Ovarian cancer chemotherapy resistance“

WashU Medicine

Matt Knarr, PhD

"'Nervous in the service' TRPV1+ tumor innervation as a novel driver of ovarian cancer progression"

UPenn Medicine